Anti‐staphylococcal activity of a cyclic lipopeptide, C 15 ‐bacillomycin D, produced by Bacillus velezensis NST6

AIM: The aim of this study was to assess antibacterial activity of a novel Bacillus velezensis strain NST6, and further identify its active compound against pathogenic Staphylococcus strains for clinical therapeutic applications. METHODS AND RESULTS: -bacillomycin D as the anti-staphylococcal compound produced by the strain. CONCLUSION: -bacillomycin D, which proved its potential to treat Staphylococcus strains in vitro and in vivo experiments with insignificant level of toxicity. SIGNIFICANCE AND IMPACT OF THE STUDY: -bacillomycin D produced by a B. velezensis strain.